Jim Fong
Corporate Officer/Principal bij CTI BIOPHARMA CORP.
Profiel
Jim Fong is currently the Chief Commercial Officer & Executive VP at CTI BioPharma Corp.
He previously worked as the Director-National Sales at CV Therapeutics, Inc. Mr. Fong completed his undergraduate degree at the University of California, Los Angeles.
Actieve functies van Jim Fong
| Bedrijven | Functie | Begin |
|---|---|---|
| CTI BIOPHARMA CORP. | Corporate Officer/Principal | 01-01-2008 |
Eerdere bekende functies van Jim Fong
| Bedrijven | Functie | Einde |
|---|---|---|
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Sales & Marketing | - |
Opleiding van Jim Fong
| University of California, Los Angeles | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
CTI BioPharma Corp.
 CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology CTI BioPharma Corp. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. It focuses on evaluating pacritinib, its sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA. | Health Technology |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Health Technology |
